Physician profile
Jerry V Thomas
NPI 1891777090
$1,070.31
in general payments reported to CMS, 2019-2025
17 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $200 · 2022: $161 · 2023: $224 · 2024: $58.97 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $233.53 | 2019-2022 | |
| Amgen INC. | $155.36 | 2020-2025 | Evenity |
| Pfizer INC. | $123.89 | 2019-2023 | |
| Abbvie INC. | $84.25 | 2022-2024 | Ubrelvy, Vraylar |
| Merck Sharp & Dohme LLC | $73.38 | 2022-2025 | Gardasil 9, Pneumovax 23, Vaxneuvance |
| Abbott Laboratories | $70.38 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Corvista Health, INC. | $63.86 | 2025 | Corvista System |
| Teleflex LLC | $63.18 | 2023 | Urolift |
| Novartis Pharmaceuticals Corporation | $35.00 | 2019 | |
| Dexcom, INC. | $34.73 | 2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $26.51 | 2019 | |
| Alnylam Pharmaceuticals INC. | $22.29 | 2022 | |
| Astellas Pharma US INC | $19.66 | 2025 | Veozah |
| Horizon Therapeutics Plc | $19.47 | 2022 | |
| Lilly USA, LLC | $16.65 | 2025 | Mounjaro, Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.47 | 2019 | |
| Cvrx, INC. | $12.70 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.